Bill Meury, Anthos Therapeutics CEO
Weeks after closing Bristol Myers deal, Karuna's ex-CEO heads to Blackstone-backed Anthos
How does Bill Meury celebrate a $14 billion merger? With a new post at a Blackstone-founded biotech.
Meury has been appointed CEO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
